Traditional Chinese Medicine Prolongs Progression-Free Survival and Enhances Therapeutic Effects in Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI)Treated Non-Small-Cell Lung Cancer (NSCLC) Patients Harboring EGFR Mutations

Documenti analoghi

• The Efficacy of Upfront Intracranial Radiation with TKI Compared to TKI Alone in the NSCLC Patients Harboring EGFR Mutation and Brain Metastases
  di: Wang, Chunyu, et al.
  Pubblicazione: (2019)
• Transglutaminase 2 induces intrinsic EGFR-TKI resistance in NSCLC harboring EGFR sensitive mutations
  di: Choi, Junyoung, et al.
  Pubblicazione: (2019)
• Chinese Medicine Combined With EGFR-TKIs Prolongs Progression-Free Survival and Overall Survival of Non-small Cell Lung Cancer (NSCLC) Patients Harboring EGFR Mutations, Compared With the Use of TKIs Alone
  di: Wang, Yujia, et al.
  Pubblicazione: (2021)
• EGFR-TKI resistance in NSCLC patients: mechanisms and strategies
  di: Lin, Yuxin, et al.
  Pubblicazione: (2014)
• Impact of Weight Loss at Presentation on Survival in Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR-TKI) Sensitive Mutant Advanced Non-small Cell Lung Cancer (NSCLC) Treated with First-line EGFR-TKI
  di: Lin, Liping, et al.
  Pubblicazione: (2018)